Search Results 41-50 of 17438 for triple negative breast cancer

1. A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer - Mayo Clinic

   ... Triple Negative Breast Cancer. Print details. Share; Facebook · Twitter ... negative (triple-negative) cancer of the breast. ECOG Performance status of ...

2. Buh-Bye, Breast Cancer? - Mayo Clinic News Network

   Knutson has developed a vaccine that could prevent all three subtypes of the disease — estrogen receptor (ER)-positive, HER2-positive and triple-negative. The ...

3. Mayo breast cancer study provides critical information on tumor sequencing and response to chemotherapy

   ... breast cancer cells into mouse avatars in more than 50 percent of patients with TNBC. “The simultaneous generation of avatars and tumor sequence data from ...

4. Chemotherapy-Resistant Breast Cancer: BEAUTY2 Study - Center for Individualized Medicine - Mayo Clinic Research

   All women with triple-negative invasive breast cancer treated with anthracycline- and taxane-based chemotherapy, with or without pembrolizumab, are eligible to ...

5. Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer - Mayo Clinic

   Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer.

6. Mayo Clinic Comprehensive Cancer Center — Research

   Hormone receptors like ER beta allow the body to respond appropriately to hormones. Triple negative means that the breast cancer does not express other hormone ...

7. A Study Assessing the Effectiveness and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced Triple Negative Breast Cancer - Mayo Clinic

   A Study Assessing the Effectiveness and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced Triple Negative Breast Cancer · Overview · Participation ...

8. Study of Magrolimab Combination Therapy to Treat Unresectable, Locally Advanced or Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   Study of Magrolimab Combination Therapy to Treat Unresectable, Locally Advanced or Metastatic Triple-Negative Breast Cancer · More about research at Mayo Clinic.

9. Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer - Mayo Clinic

   ... Triple Negative Inflammatory Breast Cancer ... Patients must have known ER, PR, and HER2 status defined as triple-negative breast cancer (TNBC), defined as:.

10. Recurrent breast cancer - Diagnosis and treatment - Mayo Clinic

    ... cancer cells don't have receptors for estrogen, progesterone or HER2. For triple-negative breast cancer, immunotherapy is combined with chemotherapy to ...